Patents by Inventor Rongliang WANG

Rongliang WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG FOR TREATING TUMOR
    Publication number: 20230310596
    Abstract: The present invention belongs to the field of biomedicines, relates to a drug for treating tumors, and provides use of an anti-PD-L1 antibody or a pharmaceutical composition thereof in preparation of a drug for treating endometrial cancer. Also provided is use of the anti-PD-L1 antibody or the pharmaceutical composition thereof in preparation of a drug for treating a MSI-H and/or dMMR tumor. In addition, also provided is use of a pharmaceutical combination of the anti-PD-L1 antibody and Anlotinib or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof in preparation of a drug for treating endometrial cancer.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 5, 2023
    Inventors: Nan SU, Xiquan ZHANG, Jie CHEN, Xunqiang WANG, Kun LI, Ding YU, Rongliang WANG
  • COMBINATION DRUG FOR TREATING KIDNEY CANCER
    Publication number: 20230227556
    Abstract: The present invention relates to the field of biomedicines. Disclosed is a combination drug for treating kidney cancer, comprising an anti-PD-L1 antibody and anlotinib or a pharmaceutically acceptable salt thereof. The present invention also provides use of the combination drug in the preparation of drugs for treating kidney cancer.
    Type: Application
    Filed: April 30, 2021
    Publication date: July 20, 2023
    Inventors: Anqi YANG, Xiquan ZHANG, Xunqiang WANG, Ding YU, Lin LI, Rongliang WANG